Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Non-Current Assets: 2010-2020

Historic Non-Current Assets for Neurocrine Biosciences (NBIX) over the last 11 years, with Dec 2020 value amounting to $718.5 million.

  • Neurocrine Biosciences' Non-Current Assets rose 192.62% to $1.0 billion in Q3 2021 from the same period last year, while for Sep 2021 it was $1.0 billion, marking a year-over-year increase of 192.62%. This contributed to the annual value of $718.5 million for FY2020, which is 51.26% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Non-Current Assets stood at $718.5 million for FY2020, which was up 51.26% from $475.0 million recorded in FY2019.
  • Over the past 5 years, Neurocrine Biosciences' Non-Current Assets peaked at $718.5 million during FY2020, and registered a low of $54.6 million during FY2016.
  • In the last 3 years, Neurocrine Biosciences' Non-Current Assets had a median value of $475.0 million in 2019 and averaged $483.0 million.
  • In the last 5 years, Neurocrine Biosciences' Non-Current Assets tumbled by 39.76% in 2016 and then surged by 380.70% in 2017.
  • Neurocrine Biosciences' Non-Current Assets (Yearly) stood at $54.6 million in 2016, then spiked by 380.70% to $262.7 million in 2017, then declined by 2.78% to $255.4 million in 2018, then surged by 86.00% to $475.0 million in 2019, then soared by 51.26% to $718.5 million in 2020.